Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor

Denise A. Yardley, Roohi R. Ismail-Khan, Bohuslav Melichar, Mikhail Lichinitser, Pamela N. Munster, Pamela M. Klein, Scott Cruickshank, Kathy D. Miller, Min J. Lee, Jane B. Trepel

Research output: Contribution to journalArticle

232 Scopus citations

Fingerprint Dive into the research topics of 'Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor'. Together they form a unique fingerprint.

Medicine & Life Sciences